Interleukin Enhancer Binding Factor 2, 45kDa (ILF2) Peptid
ILF2
Reaktivität: Human
Wirt: Synthetic
BP, BI
-
- Target Alle ILF2 Produkte
- ILF2 (Interleukin Enhancer Binding Factor 2, 45kDa (ILF2))
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), BioImaging (BI)
- Produktmerkmale
- NF45 peptide corresponds to 13 amino acids of NF45.
-
-
- Applikationshinweise
- NF45 Peptide is used for blocking the activity of NF45 antibody . The NF45 antibody ships at 0.5 mg/mL and the NF45 Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- NF45 peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. When reconstituted minimize freezing and thawing.
-
-
Sie sind hier:
